Novavax Becomes Australias 5ThApproved Covid-19 Vaccine

Novavax Becomes Australias 5ThApproved Covid-19 Vaccine

By, Admin 21 January 2022

The Country Has Ordered 51 Million Doses Of The Us-Manufactured Vaccine, Supplied Under The Brand Nuvaxovid, For Its Population Of 26 Million. Pfizer, Astrazeneca And Moderna Vaccines Are Already In Use In Australia.Novavax'S Covid19 Vaccine On Thursday Became The Fifth Coronavirus Vaccine Approved For Use In Australia. The Country Has Ordered 51 Million Doses Of The Usmanufactured Vaccine, Supplied Under The Brand Nuvaxovid, For Its Population Of 26 Million. Pfizer, Astrazeneca And Moderna Vaccines Are Already In Use In Australia. Johnson And Johnson'S Janssen Vaccine Is Also Approved But The Government Has Not Bought Any. The Novavax Vaccine Will Be Available To Unvaccinated Australians Aged 18 Years And Older But Will Not Be Used As A Booster For The 95% Of The Population Aged 16 And Older Who Have Already Received A VaccineThere Are Some Individuals, Notwithstanding A Massive Take Up Of Vaccination In This Country, Who Have Been Waiting For Novavax, And It'S Great That It'S Finally Been Approved," Said Chief Regulator John Skerritt, Head Of The Therapeutic Goods Administration. "Our Dream Is We Might Turn Our 95% Into A 97 Or 98% In This Country," Skerritt Added. The Protein-Based Vaccine Is To Be Administered In Two Doses Three Weeks Apart. Paul Griffin, Associate Professor Of Medicine At Queensland University, Said Australia Needed To Strive To Improve An Already Impressive Vaccination Rate. "For A Variety Of Reasons, It Seems Some Have Remained Reluctant To Receive These Vaccines Thus Far So An Additional Option, Based On What Is Considered Perhaps A More Traditional Platform, Is Likely To Increase Our Vaccination Rate Even Further," Griffin Said.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!